Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Liver Diseases

  Free Subscription


17.12.2018

1 Am J Gastroenterol
2 Biochem Biophys Res Commun
9 BMC Cancer
2 BMC Gastroenterol
1 Br J Surg
2 Cancer Res
1 Endoscopy
7 Eur Radiol
5 Gastroenterology
2 Gastrointest Endosc
9 Hepatology
1 Indian J Gastroenterol
1 J Gastroenterol Hepatol
4 J Hepatol
1 J Pediatr Surg
2 Oncogene
3 PLoS One
2 Proc Natl Acad Sci U S A
4 Transplantation


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Gastroenterol

  1. PETTINARI I, Vukotic R, Stefanescu H, Pecorelli A, et al
    Clinical Impact and Safety of Anticoagulants for Portal Vein Thrombosis in Cirrhosis.
    Am J Gastroenterol. 2018 Dec 11. pii: 10.1038/s41395-018-0421.
    PubMed     Text format     Abstract available


    Biochem Biophys Res Commun

  2. YANG T, Gao Y, Liu D, Wang Y, et al
    ASPP2 enhances chemotherapeutic sensitivity through the down-regulation of XIAP expression in a p53 independent manner in hepatocellular carcinoma.
    Biochem Biophys Res Commun. 2018 Dec 6. pii: S0006-291X(18)32616.
    PubMed     Text format     Abstract available

  3. SUN Y, Xu H, Chen X, Li X, et al
    Inhibition of mitochondrial respiration overcomes hepatocellular carcinoma chemoresistance.
    Biochem Biophys Res Commun. 2018 Dec 4. pii: S0006-291X(18)32617.
    PubMed     Text format     Abstract available


    BMC Cancer

  4. DA FONSECA LG, Marta GN, Braghiroli MIFM, Chagas AL, et al
    Safety and efficacy of cytotoxic chemotherapy in hepatocellular carcinoma after first-line treatment with sorafenib.
    BMC Cancer. 2018;18:1250.
    PubMed     Text format     Abstract available

  5. CHEN Y, Zhao J, Jiao Z, Wang W, et al
    SKA1 overexpression is associated with poor prognosis in hepatocellular carcinoma.
    BMC Cancer. 2018;18:1240.
    PubMed     Text format     Abstract available

  6. KIM H, Kim Y, Chung Y, Abdul R, et al
    Single-stranded DNA binding protein 2 expression is associated with patient survival in hepatocellular carcinoma.
    BMC Cancer. 2018;18:1244.
    PubMed     Text format     Abstract available

  7. MATSUSHITA J, Okamura K, Nakabayashi K, Suzuki T, et al
    The DNA methylation profile of liver tumors in C3H mice and identification of differentially methylated regions involved in the regulation of tumorigenic genes.
    BMC Cancer. 2018;18:317.
    PubMed     Text format     Abstract available

  8. MOLE DJ, Fallowfield JA, Kendall TJ, Welsh F, et al
    Study protocol: HepaT1ca - an observational clinical cohort study to quantify liver health in surgical candidates for liver malignancies.
    BMC Cancer. 2018;18:890.
    PubMed     Text format     Abstract available

  9. HUANG D, Bi C, Zhao Q, Ding X, et al
    Knockdown long non-coding RNA ANRIL inhibits proliferation, migration and invasion of HepG2 cells by down-regulation of miR-191.
    BMC Cancer. 2018;18:919.
    PubMed     Text format     Abstract available

  10. SHIBUTANI M, Maeda K, Nagahara H, Fukuoka T, et al
    A comparison of the local immune status between the primary and metastatic tumor in colorectal cancer: a retrospective study.
    BMC Cancer. 2018;18:371.
    PubMed     Text format     Abstract available

  11. LI Y, Chen G, Chen H, Wen S, et al
    Spontaneous renal hemorrhage secondary to choriocarcinoma in a man with congenital hypospadias and cryptorchidism: a case report and literature review.
    BMC Cancer. 2018;18:543.
    PubMed     Text format     Abstract available

  12. HE S, Hu B, Li C, Lin P, et al
    PDXliver: a database of liver cancer patient derived xenograft mouse models.
    BMC Cancer. 2018;18:550.
    PubMed     Text format     Abstract available


    BMC Gastroenterol

  13. FOSCHI FG, Bedogni G, Domenicali M, Giacomoni P, et al
    Prevalence of and risk factors for fatty liver in the general population of Northern Italy: the Bagnacavallo Study.
    BMC Gastroenterol. 2018;18:177.
    PubMed     Text format     Abstract available

  14. HU J, Wang N, Yang Y, Ma L, et al
    Diagnostic value of alpha-fetoprotein combined with neutrophil-to-lymphocyte ratio for hepatocellular carcinoma.
    BMC Gastroenterol. 2018;18:186.
    PubMed     Text format     Abstract available


    Br J Surg

  15. GRUT H, Solberg S, Seierstad T, Revheim ME, et al
    Growth rates of pulmonary metastases after liver transplantation for unresectable colorectal liver metastases.
    Br J Surg. 2018;105:295-301.
    PubMed     Text format     Abstract available


    Cancer Res

  16. GU Y, Wei X, Sun Y, Gao H, et al
    miR-192-5p silencing by genetic aberrations is a key event in hepatocellular carcinomas with cancer stem cell features.
    Cancer Res. 2018 Dec 7. pii: 0008-5472.CAN-18-1675.
    PubMed     Text format     Abstract available

  17. WOHLFEIL SA, Hafele V, Dietsch B, Schledzewski K, et al
    Hepatic endothelial Notch activation protects against liver metastasis by regulating endothelial-tumor cell adhesion independent of angiocrine signaling.
    Cancer Res. 2018 Dec 10. pii: 0008-5472.CAN-18-1752.
    PubMed     Text format     Abstract available


    Endoscopy

  18. MANDAI K, Uno K, Yasuda K
    Endoscopic lithotripsy for right intrahepatic bile duct stone through endoscopic ultrasound-guided hepaticogastrostomy.
    Endoscopy. 2018 Dec 11. doi: 10.1055/a-0800-8429.
    PubMed     Text format    


    Eur Radiol

  19. BREGUET R, Boudabbous S, Pupulim LF, Becker CD, et al
    Ethylene vinyl alcohol copolymer for occlusion of specific portal branches during preoperative portal vein embolisation with n-butyl-cyanoacrylate.
    Eur Radiol. 2018;28:4810-4817.
    PubMed     Text format     Abstract available

  20. KIM C, Kim SY, Kim MJ, Yoon YS, et al
    Clinical impact of preoperative liver MRI in the evaluation of synchronous liver metastasis of colon cancer.
    Eur Radiol. 2018;28:4234-4242.
    PubMed     Text format     Abstract available

  21. FAZELI DEHKORDY S, Fowler KJ, Mamidipalli A, Wolfson T, et al
    Hepatic steatosis and reduction in steatosis following bariatric weight loss surgery differs between segments and lobes.
    Eur Radiol. 2018 Dec 13. pii: 10.1007/s00330-018-5894.
    PubMed     Text format     Abstract available

  22. KHOURI CHALOUHI C, Vernuccio F, Rini F, Duca P, et al
    Hepatobiliary phase in cirrhotic patients with different Model for End-stage Liver Disease score: comparison of the performance of gadoxetic acid to gadobenate dimeglumine.
    Eur Radiol. 2018 Dec 13. pii: 10.1007/s00330-018-5884.
    PubMed     Text format     Abstract available

  23. DONG Z, Huang K, Liao B, Cai H, et al
    Prediction of sorafenib treatment-related gene expression for hepatocellular carcinoma: preoperative MRI and histopathological correlation.
    Eur Radiol. 2018 Dec 13. pii: 10.1007/s00330-018-5882.
    PubMed     Text format     Abstract available

  24. NEIJENHUIS MK, Wijnands TFM, Kievit W, Ronot M, et al
    Symptom relief and not cyst reduction determines treatment success in aspiration sclerotherapy of hepatic cysts.
    Eur Radiol. 2018 Dec 12. pii: 10.1007/s00330-018-5851.
    PubMed     Text format     Abstract available

  25. BISE S, Frulio N, Hocquelet A, Alberti N, et al
    New MRI features improve subtype classification of hepatocellular adenoma.
    Eur Radiol. 2018 Dec 6. pii: 10.1007/s00330-018-5784.
    PubMed     Text format     Abstract available


    Gastroenterology

  26. LIDOFSKY SD
    Screening For Hepatocellular Carcinoma In Cirrhosis: Challenges And Unresolved Issues.
    Gastroenterology. 2018 Dec 10. pii: S0016-5085(18)35390.
    PubMed     Text format    

  27. MEHTA N, Monto A, Yao FY
    Screening for hepatocellular carcinoma to improve cancer-related mortality: Looking behind when we should be looking ahead.
    Gastroenterology. 2018 Dec 10. pii: S0016-5085(18)35392.
    PubMed     Text format    

  28. MAJEED A, Roberts SK, Kemp W
    RE: No Association Between Screening for Hepatocellular Carcinoma and Reduced Cancer-Related Mortality in Patients with Cirrhosis.
    Gastroenterology. 2018 Dec 10. pii: S0016-5085(18)35391.
    PubMed     Text format    

  29. SINGAL AG, Murphy CC
    Hepatocellular Carcinoma Surveillance: An effective but complex process.
    Gastroenterology. 2018 Dec 10. pii: S0016-5085(18)35393.
    PubMed     Text format    

  30. MAHER JJ
    Macrophages Steal STING From the Infectious Disease Playbook to Promote Nonalcoholic Fatty Liver Disease.
    Gastroenterology. 2018;155:1687-1688.
    PubMed     Text format    


    Gastrointest Endosc

  31. NAKAZURU S, Sakakibara Y, Ishida H, Mori K, et al
    Gastric metastasis from pancreatic neuroendocrine tumor.
    Gastrointest Endosc. 2018 Apr 7. pii: S0016-5107(18)30271.
    PubMed     Text format    

  32. RAMOS GP, Binder M, Hampel P, Braga Neto MB, et al
    Outcomes of endoscopic intervention for overt GI bleeding in severe thrombocytopenia.
    Gastrointest Endosc. 2018;88:55-61.
    PubMed     Text format     Abstract available


    Hepatology

  33. RAND EB
    Cirrhotic Cardiomyopathy in children with BA: A new objective parameter to predict morbidity and mortality on the waitlist - and beyond!
    Hepatology. 2018 Dec 12. doi: 10.1002/hep.30419.
    PubMed     Text format     Abstract available

  34. MEHTA N, Dodge JL, Roberts JP, Hirose R, et al
    Alpha-fetoprotein Decrease from >1000 to <500 ng/ml in Patients with Hepatocellular Carcinoma Leads to Improved Post-Transplant Outcomes.
    Hepatology. 2018 Dec 13. doi: 10.1002/hep.30413.
    PubMed     Text format     Abstract available

  35. UNZU C, Planet E, Brandenberg N, Fusil F, et al
    Pharmacological induction of a progenitor state for the efficient expansion of primary human hepatocytes.
    Hepatology. 2018 Dec 14. doi: 10.1002/hep.30425.
    PubMed     Text format     Abstract available

  36. HERNAEZ R, Kanwal F, El-Serag HB
    Hepatocellular carcinoma screening is associated with survival benefit in silico but needs confirmation in an in vivo analysis.
    Hepatology. 2018;68:7-9.
    PubMed     Text format    

  37. ARMENGOL C, Cairo S
    Identification of theranostic biomarkers to improve the stratification of patients with pediatric liver cancer: Opportunities and challenges.
    Hepatology. 2018;68:10-12.
    PubMed     Text format    

  38. GULAMHUSEIN AF, Lazaridis KN
    Primary Biliary Cholangitis, DNA and Beyond: The Relative Contribution of Genes.
    Hepatology. 2018 Jan 13. doi: 10.1002/hep.29783.
    PubMed     Text format    

  39. CARR RM
    Proton pump inhibitors, Enterococcus, and the liver, oh my!
    Hepatology. 2018;68:376-379.
    PubMed     Text format    

  40. VERMA N, Singh A, Singh V
    Reply.
    Hepatology. 2018;68:388.
    PubMed     Text format    

  41. POLYZOS SA, Kountouras J, Anastasiadis S, Doulberis M, et al
    Nonalcoholic fatty liver disease: Is it time for combination treatment and a diabetes-like approach?
    Hepatology. 2018;68:389.
    PubMed     Text format    


    Indian J Gastroenterol

  42. JHA SK, Mishra M, Jha A, Dayal VM, et al
    Reply to the letter to Editor on comparison of continuous versus intermittent infusions of terlipressin for the control of acute variceal bleeding in patients with portal hypertension: An open-label randomized controlled trial.
    Indian J Gastroenterol. 2018 Dec 10. pii: 10.1007/s12664-018-0917.
    PubMed     Text format    


    J Gastroenterol Hepatol

  43. TEJEDOR-TEJADA J, Garcia-Pajares F, Madrigal Rubiales B
    Hepatobiliary and Pancreatic: Sertraline-induced vanishing bile duct syndrome treated with plasmapheresis.
    J Gastroenterol Hepatol. 2018 Dec 9. doi: 10.1111/jgh.14503.
    PubMed     Text format    


    J Hepatol

  44. BOEREKAMPS A, Vanwolleghem T, van der Valk M, van den Berk GE, et al
    8 weeks of sofosbuvir/ledipasvir is effective in DAA-naive non-cirrhotic HCV genotype 4 infected patients (HEPNED-001 study).
    J Hepatol. 2018 Dec 5. pii: S0168-8278(18)32516.
    PubMed     Text format    

  45. PARK JW, Kim YJ, Kim DY, Bae SH, et al
    Sorafenib with or without concurrent transarterial chemoembolization in patients with advanced hepatocellular carcinoma: a phase III STAH trial.
    J Hepatol. 2018 Dec 5. pii: S0168-8278(18)32580.
    PubMed     Text format     Abstract available

  46. RINELLA ME, Trotter JF, Abdelmalek MF, Paredes AH, et al
    Rosuvastatin improves the FGF19 analogue NGM282-associated lipid changes in patients with nonalcoholic steatohepatitis.
    J Hepatol. 2018 Dec 7. pii: S0168-8278(18)32615.
    PubMed     Text format     Abstract available

  47. GUSTOT T, Agarwal B
    Selected patients with acute-on-chronic liver failure grade 3 are not too sick to be considered for liver transplantation.
    J Hepatol. 2017;67:667-668.
    PubMed     Text format    


    J Pediatr Surg

  48. LEMOINE C, Nilsen A, Brandt K, Mohammad S, et al
    Liver histopathology in patients with hepatic masses and the Abernethy malformation.
    J Pediatr Surg. 2018 Nov 7. pii: S0022-3468(18)30743.
    PubMed     Text format     Abstract available


    Oncogene

  49. ZHANG H, Deng T, Ge S, Liu Y, et al
    Exosome circRNA secreted from adipocytes promotes the growth of hepatocellular carcinoma by targeting deubiquitination-related USP7.
    Oncogene. 2018 Dec 13. pii: 10.1038/s41388-018-0619.
    PubMed     Text format     Abstract available

  50. AHODANTIN J, Bou-Nader M, Cordier C, Megret J, et al
    Hepatitis B virus X protein promotes DNA damage propagation through disruption of liver polyploidization and enhances hepatocellular carcinoma initiation.
    Oncogene. 2018 Dec 11. pii: 10.1038/s41388-018-0607.
    PubMed     Text format     Abstract available


    PLoS One

  51. WANG HW, Shi HN, Cheng J, Xie F, et al
    Real-time shear wave elastography (SWE) assessment of short- and long-term treatment outcome in Budd-Chiari syndrome: A pilot study.
    PLoS One. 2018;13:e0197550.
    PubMed     Text format     Abstract available

  52. MILLINGS EJ, De Rosa MC, Fleet S, Watanabe K, et al
    ILDR2 has a negligible role in hepatic steatosis.
    PLoS One. 2018;13:e0197548.
    PubMed     Text format     Abstract available

  53. UMEHARA T
    Nonalcoholic fatty liver disease with elevated alanine aminotransferase levels is negatively associated with bone mineral density: Cross-sectional study in U.S. adults.
    PLoS One. 2018;13:e0197900.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  54. WANG R, Li Y, Tsung A, Huang H, et al
    iNOS promotes CD24(+)CD133(+) liver cancer stem cell phenotype through a TACE/ADAM17-dependent Notch signaling pathway.
    Proc Natl Acad Sci U S A. 2018 Oct 8. pii: 1722100115.
    PubMed     Text format     Abstract available

  55. KODAMA T, Yi J, Newberg JY, Tien JC, et al
    Molecular profiling of nonalcoholic fatty liver disease-associated hepatocellular carcinoma using SB transposon mutagenesis.
    Proc Natl Acad Sci U S A. 2018;115:E10417-E10426.
    PubMed     Text format     Abstract available


    Transplantation

  56. YAO S, Yagi S, Uozumi R, Iida T, et al
    A high portal venous pressure gradient increases gut-related bacteremia and consequent early mortality after living donor liver transplantation.
    Transplantation. 2018 Jan 10. doi: 10.1097/TP.0000000000002047.
    PubMed     Text format     Abstract available

  57. BEZINOVER D, Dirkmann D, Findlay J, Guta C, et al
    Perioperative Coagulation Management in Liver Transplant Recipients.
    Transplantation. 2018 Jan 15. doi: 10.1097/TP.0000000000002092.
    PubMed     Text format     Abstract available

  58. SPENGLER EK
    The Author's Reply.
    Transplantation. 2018;102:e189-e190.
    PubMed     Text format    

  59. SAVALE L, Duclos-Vallee JC, Sitbon O
    Outcome of portopulmonary hypertension after liver transplantation: perhaps not so optimistic.
    Transplantation. 2018 Feb 2. doi: 10.1097/TP.0000000000002112.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: